CATAPANO, Francesco
 Distribuzione geografica
Continente #
EU - Europa 13.941
NA - Nord America 8.188
AS - Asia 4.757
SA - Sud America 864
Continente sconosciuto - Info sul continente non disponibili 167
AF - Africa 66
OC - Oceania 25
AN - Antartide 1
Totale 28.009
Nazione #
US - Stati Uniti d'America 7.928
RU - Federazione Russa 7.031
IT - Italia 2.591
SG - Singapore 1.812
IE - Irlanda 1.257
CN - Cina 853
UA - Ucraina 852
HK - Hong Kong 795
BR - Brasile 743
GB - Regno Unito 567
VN - Vietnam 533
DE - Germania 481
FR - Francia 370
FI - Finlandia 218
SE - Svezia 204
JP - Giappone 182
TR - Turchia 165
GR - Grecia 158
IN - India 149
KR - Corea 102
CA - Canada 75
NL - Olanda 50
AR - Argentina 40
PL - Polonia 35
ID - Indonesia 28
ZA - Sudafrica 28
CR - Costa Rica 27
BE - Belgio 25
NI - Nicaragua 25
AU - Australia 24
EC - Ecuador 24
BD - Bangladesh 23
PR - Porto Rico 22
ES - Italia 21
HN - Honduras 21
IQ - Iraq 21
CH - Svizzera 18
GT - Guatemala 18
SV - El Salvador 18
CW - ???statistics.table.value.countryCode.CW??? 16
AT - Austria 15
GP - Guadalupe 15
PY - Paraguay 14
TT - Trinidad e Tobago 14
CO - Colombia 13
MX - Messico 12
CL - Cile 11
RO - Romania 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
MY - Malesia 9
PE - Perù 9
PK - Pakistan 9
DZ - Algeria 8
MA - Marocco 8
EG - Egitto 7
NP - Nepal 7
CZ - Repubblica Ceca 6
LT - Lituania 6
SA - Arabia Saudita 6
AL - Albania 5
EU - Europa 5
IL - Israele 5
KE - Kenya 5
IR - Iran 4
JM - Giamaica 4
JO - Giordania 4
LB - Libano 4
PH - Filippine 4
PT - Portogallo 4
RS - Serbia 4
TN - Tunisia 4
VE - Venezuela 4
AZ - Azerbaigian 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
KZ - Kazakistan 3
PA - Panama 3
TW - Taiwan 3
BN - Brunei Darussalam 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
PS - Palestinian Territory 2
SI - Slovenia 2
TH - Thailandia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
LC - Santa Lucia 1
Totale 27.855
Città #
Moscow 2.442
Jacksonville 1.259
Dublin 1.248
San Jose 866
Santa Clara 853
Hong Kong 793
Ashburn 663
Singapore 610
Council Bluffs 465
Chandler 430
Princeton 237
Milan 206
Ho Chi Minh City 187
Roxbury 164
Medford 158
New York 153
Rome 147
Bremen 144
Beijing 136
Hanoi 116
Wilmington 105
Ann Arbor 104
Boardman 102
Seoul 91
The Dalles 91
Naples 87
Caserta 76
Cambridge 72
Dallas 71
Bengaluru 70
Woodbridge 66
San Mateo 65
São Paulo 60
Hefei 58
Miano 52
Fisciano 49
Aversa 44
Des Moines 41
Nanjing 41
Los Angeles 38
Catania 33
Da Nang 33
Düsseldorf 33
Napoli 32
Bologna 31
Atlanta 30
Florence 30
Marigliano 30
Tokyo 28
Jinan 27
Palermo 26
Orem 25
Managua 24
Houston 23
Norwalk 23
Seattle 23
Turin 23
Brooklyn 22
Bari 21
Brasília 21
Haiphong 21
Memphis 21
San José 21
Montreal 20
Munich 20
Brussels 17
Padova 17
Porto Alegre 17
Rio de Janeiro 17
San Salvador 17
Willemstad 16
Belo Horizonte 15
Cagliari 15
Chicago 15
Istanbul 15
Torino 15
Frankfurt am Main 14
Johannesburg 14
Nanchang 14
Nuremberg 14
San Prisco 14
Guangzhou 13
Hangzhou 13
Parma 13
Radomsko 13
Shenyang 13
Guatemala City 12
Guayaquil 12
Mountain View 12
Sulzbach-Rosenberg 12
Vienna 12
Warsaw 12
Boston 11
Denver 11
Mumbai 11
Perugia 11
Redwood City 11
San Francisco 11
San Juan 11
Tashkent 11
Totale 13.772
Nome #
SINDROME METABOLICA E TRATTAMENTO CON ANTIPSICOTICI: DIFFERENZE IN PAZIENTI CON DIAGNOSI DI SCHIZOFRENIA E DISTURBO BIPOLARE 679
Discrasie ematiche transitorie e persistenti indotte dalla clozapina durante le prime diciotto settimane di trattamento 555
CLOZAPINA E ALTRI ANTIPSICOTICI ATIPICI E TIPICI: INCIDENZA E DECORSO DELLE DISCRASIE EMATICHE DURANTE LE PRIME DICIOTTO SETTIMANE DI TRATTAMENTO 279
[Critical evaluation of current diagnostic classification systems in psychiatry: the case of DSM-5] 256
“Decima revisione della classificazione internazionale delle sindromi e dei disturbi psichici e comportamentali-ICD10”- Criteri diagnostici per la ricerca. 250
Duration of Untreated Illness in Patients with Obsessive-Compulsive Disorder and Its Impact on Long-Term Outcome: A Systematic Review 237
Trattamento combinato con clorimipramina ed aripiprazolo nella depressione resistente 234
TRATTAMENTO CON ANTIPSICOTICI E COMPARSA DI SINDROME METABOLICA: UNO STUDIO RETROSPETTIVO IN PAZIENTI SCHIZOFRENICI E BIPOLARI 202
Aripiprazole augmentation strategy in clomipramine-resistant depressive patients: An open preliminary study. 190
ICD-10. Descrizioni cliniche e direttive diagnostiche 189
Burden on the families of patients with obsessive-compulsive disorder: a pilot study 187
Brain natriuretic peptide as a biomarker of asymptomatic clozapine-related heart dysfunction: a criterion for a more cautious administration. 186
Vitamin D Deficiency and Risk Factors Related to Acute Psychiatric Relapses in Patients with Severe Mental Disorders: A Preliminary Study 180
Decima revisione della classificazione internazionale delle sindromi e dei disturbi psichici e comportamentali-ICD10 176
Organizational and Individual Interventions for Managing Work-Related Stress in Healthcare Professionals: A Systematic Review 175
La viloxazina: proprietà farmacologiche e profilo clinico di un antidepressivo di II generazione 171
Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature 169
Sindrome metabolica e utilizzo di antipsicotici in pazienti con diagnosi di schizofrenia e disturbo bipolare 167
Antipsychotic treatment and metabolic syndrome: a retrospective study in schizophrenic and bipolar patients 167
Trattamento con antipsicotici e sindrome metabolica: uno studio retrospettivo in pazienti schizofrenici e bipolari 165
A predictive model to allocate frequent service users of community-based Mental Health Service to different packages of care. 164
A neuropsychological study of obsessive-compulsive disorder 162
Antipsychotic treatment and metabolic syndrome: a retrospective study in schizophrenic and bipolar patients 162
L’Olanzapina è più rapida dell’Aloperidolo nell’indurre Sindrome Metabolica in pazienti schizofrenici ma non nei bipolari 162
Antipsychotic Treatment and Metabolic Syndrome: a Comparison between Schizophrenic and Bipolar Patients. 161
A Multivariate Analysis of Depression Prevalence in Psoriasis Patients: A Cohort Study 161
Abnormal bodily experiences detected by Abnormal Bodily Phenomena questionnaire are more frequent and severe in schizophrenia than in bipolar disorder with psychotic features 160
Transient and persistent blood dyscrasias induced by clozapine during the first 18 weeks of treatment 157
Circadian rhythms of melatonin, cortisol and prolactin in patients with obsessive-compulsive disorder 156
A hypothesis on Cotard’s syndrome as an evolution of obsessive-compulsive disorder 156
Antidepressivi nell'anziano 154
Aspetti biologici e terapia farmacologica dei disturbi ossessivo-compulsivi 154
The unmasking of hidden severe hyponatremia after long-term combination therapy in exacerbated bipolar patients: a case series. 153
Delirium and Psychiatric Sequelae Associated to SARS-CoV-2 in Asymptomatic Patients With Psychiatric History and Mild Cognitive Impairment as Risk Factors: Three Case Reports 152
Second-Generation Antipsychotics' Effectiveness and Tolerability: A Review of Real-World Studies in Patients with Schizophrenia and Related Disorders 150
Clozapine versus other antipsychotics during the first 18 weeks of treatment: A retrospective study on risk factor increase of blood dyscrasias 149
Use of coercive measures in mental health practice and its impact on outcome: a critical review. 147
Dimensioni sintomatologiche del disturbo ossessivo-compulsivo: caratteristiche cliniche e risposta al trattamento 147
Aspetti biologici della depressione 146
Circadian melatonin rhythm in patients with paranoid schizophrenia and obsessive-compulsive disorder 146
La depressione resistente al trattamento farmacologico: incremento dell’effetto antidepressivo della clorimipramina determinato dall’aripiprazolo 145
Studio di popolazione sulle conseguenze psicosociali di una catastrofe naturale: la frana di Sarno 144
Il trattamento dei disturbi della personalità in soggetti detenuti 143
Drug safety warnings in psychiatry: Adverse drug reactions' signaling from 2002 to 2014 143
Patient characteristics and symptoms associated with perceived coercion during hospital treatment 142
Ansia 142
Caratteristiche di personalità e stili criminali in un campione di detenuti minorenni 142
E' ancora manicomio: prima fase di un possibile progetto di intervento nell'Ospedale Psichiatrico 140
Correlati neurofisiologici della risposta clinica ai neurolettici tipici in pazienti schizofrenici al primo episodio di malattia 139
ICD-10. Criteri diagnostici per la ricerca 138
Shall psychiatry change its target? Reflections on the evolving role of psychiatry 138
Factors Associated with Anxiety, Depression, and Quality of Life in Patients with Psoriasis: A Cross-Sectional Study 136
Effetto dell'abuso di cannabis sulla durata della psicosi non trattata 136
Urban insecurity and fear of crime in people suffering from mental disorders: a study in 24 Mental Health Centers in Italy 136
Obsessive-compulsive disorder: A 3-year prospective follow-up study of patients treated with serotonin reuptake inhibitors. 135
I pazienti ossessivi con ridotto insight: caratteristiche cliniche e risposte al trattamento 135
Insight e resistenza nei pazienti ossessivi 135
Cortisol response to d-fenfluramine in drug-free patients with obsessive-compulsive disorder 135
Risposta al trattamento con inibitori del reuptake della serotonina nel disturbo ossessivo-compulsivo ad esordio precoce 135
Metabolic Syndrome and Antipsychotic treatment: how about schizophrenia and bipolar disorder? 135
L'antico Ospedale napoletano degli Incurabili e la pratica delle "battiture" 134
Pemphigus and skin disease: A comparison of the incidence of stressful life events and personality disorders 133
Patterns assistenziali e outcome psicosociale in pazienti schizofrenici. Studio prospettivo triennale 132
Gli ICD dell’Organizzazione Mondiale della Sanità 132
Il trattamento dei disturbi della personalità in soggetti detenuti 132
Feasibility of a psychoeducational family intervention for people with bipolar I disorder and their relatives: Results from an Italian real-world multicentre study 132
How do relatives cope with eating disorders? Results from an Italian multicentre study 132
Neurocognitive indices of executive hypercontrol in obsessive-compulsive disorder 130
Discrasie ematiche transitorie e persistenti e trattamento con clozapina nelle prime diciotto settimane di terapia 130
Combination of Two Long-Acting Antipsychotics in Schizophrenia Spectrum Disorders: A Systematic Review 129
ICD-10. Linne guida per la diagnosi e la gestione dei disturbi mentali nella medicina di base 129
Proposal for a new funding system for mental health departments. Results from a evaluative multicentre Italian study (I-psycost) 128
Plasma melatonin and cortisol circadian patterns in patients with obsessive-compulsive disorder before and after fluoxetine treatment 128
Fattori specifici e aspecifici della riabilitazione psicosociale (I parte) 128
Two Long-Acting Antipsychotics in a Patient with Treatment-Resistant Schizophrenia: A Case Report 127
Duration of untreated illness and outcome of the OCD: a three-year prospective study 127
Perceived insecurity, mental health and urbanization: Results from a multicentric study 127
Duration of untreated illness and outcome of obsessive-compulsive disorder: A naturalistic follow-up study. 127
Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder 126
Reading Group Rehabilitation for Patients with Psychosis: A Randomized Controlled Study. 126
Double dissociation of N1 and P3 abnormalities in deficit and nondeficit schizophrenia 126
The role of relatives in pathways to care of patients with a first episode of psychosis 126
What is the current status of training and practice of early intervention in psychiatry? Results from a survey in 35 countries 125
Comorbidity of obsessive-compulsive disorder and schizotypal personality disorder: Clinical response and treatment resistance to pharmacotherapy in a 3-year follow-up naturalistic study 125
The relationship between obsessive-compulsive personality and obsessive-compulsive disorder: data obtained by the Personality Disorder Examination 124
Clozapine treatment and other atypical and typical antipsychotics: incidence and course of blood dyscrasias during the first eighteen weeks of treatment 123
Olanzapine Is Faster than Haloperidol in Inducing Metabolic Abnormalities in Schizophrenic and Bipolar Patients 123
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 123
La riabilitazione psicosociale. 122
Psychosocial consequences of the 1998 landslide in Sarno, Italy 121
La sindrome metabolica e l’utilizzo di antipsicotici: quali differenze in schizofrenia e disturbo bipolare? 121
Schizofrenia e adattamento sociale: studio comparativo tra due strumenti di valutazione (S.A.S. e D.A.S.) 121
Valutazione del carico familiare in un campione di familiari di pazienti con sindrome ossessivo-compulsiva 121
Symptom dimensions and treatment response in obsessive-compulsive disorder 119
Obsessive-compulsive disorder with poor insight: clinical characteristics and treatment response 118
Clozapine induces an early improvement of "disorganization" in a group of treatment resistant schizophrenic patients 118
L'ansia , la depressione e il movimento nell'anziano 117
Social contacts and loneliness in people with psychotic and mood disorders 117
Efficacy of low vs. high doses of levosulpiride on negative symptoms of schizophrenia 116
La sindrome bipolare a cicli rapidi: riproducibilità e validità di quattro definizioni alternative e loro implicazioni cliniche 116
Totale 15.698
Categoria #
all - tutte 89.499
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.499


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.264 0 0 0 36 491 8 16 66 62 58 117 410
2022/20232.227 245 65 34 124 286 173 4 116 1.071 21 46 42
2023/20241.212 67 20 38 128 377 106 38 37 18 35 121 227
2024/20253.322 25 60 63 90 505 403 367 268 417 723 226 175
2025/202612.101 386 444 562 649 871 6.603 782 514 552 407 180 151
2026/20272.356 147 374 840 995 0 0 0 0 0 0 0 0
Totale 28.009